Microviable Therapeutics welcomes Ignacio Montero, PhD on board
Microviable Therapeutics welcomes Ignacio Montero, PhD on board. With a PhD in microbiology, extensive experience in R&D and a MS in Bioinformatics, Ignacio joins the team to work on the bioinformatic and genomics platform. Noteworthy, [...]
Rosa del Campo, PhD, MD joins our Scientific Advisory Board
We are excited to announce the appointment of Rosa del Campo, PhD, MD to our Scientific Advisory Board. As part of our strategic vision and further expansion, we are glad to work closely with clinicians [...]
8th International Human Microbiome Consortium Congress 2021
Microviable Therapeutics CEO Claudio Hidalgo will be presenting at the 8th International Human Microbiome Consortium Congress 2021 on June 28th. Claudio will discuss the use of "Purified microbiota and LPBs towards the therapeutic applications" and [...]
New member: Lara Dos Santos Rodríguez
Microviable Therapeutics welcomes Lara Dos Santos Rodríguez on board. Lara will performed her internships with us as part of her training to obtain the BS Biology at the University of Oviedo.
Microviable Therapeutics sponsor of the 8th International Human Microbiome Consortium (IHMC) Congress
Microviable Therapeutics becomes a proud sponsor of the 8th International Human Microbiome Consortium (IHMC) Congress, that will be held virtual lyon June 27th - 29th. Microviable is honored to become one of the sponsors of [...]
New member: Marta F. Gosande
Our CEO Claudio Hidalgo welcomes Marta Fdez Gosande on board. Marta will performed her Master’s Project with us as part of her training on the Microbiota, Probiotics and Prebiotics Master from the European University of [...]
Microviable Therapeutics to sponsor Pharmabiotics 2021
Microviable Therapeutics is sponsoring Pharmabiotics Event 2021, a virtual conference taking place on April 28-29. […]
We are on TV
The TV show Conexión Asturias (RTPA) showcased Microviable Therapeutics activity in the microbiota field, currently focus on live biotherapeutic products (LBPs) development for Crohn´s disease and Autism Spectrum Disorder. […]